Tertiary prevention, the last level, aims to prevent the consequences of a past injury, counteract its recurrence, and minimize secondary damage and complications
The AAFP advises that injectable therapy leads to more rapid improvement and should be considered in patients with severe deficiency or severe neurologic symptoms (Langan RC, Goodbred AJ, 2017)
This is precisely why 5-Amino-1MQ continues to garner so much interest, and why the debate around 5-Amino-1MQ oral vs injectable formulation is so vibrant
This is the dual-agonist component that tirzepatide shares with retatrutide
Who can benefit from Methylcobalamin Injection
All Adults and for Children aged three and above who are thought to be low or deficient of B12 Those who are pregnant or breastfeeding